| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |